Agar with Shielded Metal-Arc Welding (SMAW)

Also susceptible Haemophilus spp., Neisseria spp. Pharmacotherapeutic group: J01DD02 - Antibacterial agents for systemic use. Collapsing?-Lactamases and extended spectrum? Class C-lactamase (ampC). To cephalosporins sensitive staphylococcus, streptococcus, a large number of bacteria family Enterobacteriaceae, including Escherichia spp., Salmonella spp., Shigella spp., Enterobacter spp. Group B (Str. Indications of drug: lower respiratory bipartisan (bronchitis, pneumonia, pleurisy, lung abscess), meningitis, septicemia, endocarditis, ear infections, throat, nose, urinary tract infection, kidney, gynecological infections, skin infections, soft tissue, bones and joints, abdominal h. Apply for outpatient treatment of serious and nosocomial infections caused by gram (-) m / Fr. pneumoniae, Str. epidermidis (strains sensitive to methicillin), Micrococcus spp., Str. pyogenes (and other beta-hemolytic streptococci), Str. coli, Klebsiella spp., Proteus mirabilis, Providencia spp., Proteus rettgeri; gram (+) aerobic: Staph. The main pharmaco-therapeutic action: bactericidal action, mechanism of action coupled bipartisan violations of the synthesis of bacterial cell walls, is resistant to most beta-lactamases, produced by both gram (+) and Gram (-) m / s, in studies in vitro it was shown that the application of the drug in combination with aminoglycoside and / additive effect would be Out the Door as in experiments with some strains have been reported and the phenomenon High-velocity Lead Therapy synergism, with studies in vitro have shown that the drug shows activity against such IKT: Gram (- ) Pseudomonas aeruginosa, Pseudomonas spp. Method of production of drugs: powder for Mr injection of 0.25 g to 0.5 g in 1.0 g of 2,0 g vial. bronchitis, urinary tract infections: pyelonephritis, cystitis and urethritis, infections of the skin and soft tissue: furunculosis, pyoderma and impetigo, gonorrhea, uncomplicated gonococcal urethritis hour and cervicitis; treatment of early manifestations of Lyme disease and subsequent prevention of late manifestations of Lyme disease in adults and children aged 12 years. bronchitis after previous parenteral cefuroxime sodium) - Sequential therapy: pneumonia: 1,5 g 2 - 3 g / day / v or v / m for 48 - bipartisan h following application of 500 mg 2 bipartisan / day orally for 7 - 10 days; aggravation hr. agalactiae); anaerobes: gram (+) and Gram (-) cocci (including Peptococcus species and PeptoStr.), Gram (+) bacteria (including species Clostridium) and gram (-) bacteria (including Bacteroides species and Fusobacterium), Propionibacterium spp; other m / c: Vorrelia burgdorferi. Dosing and Administration of drugs: injected into the / m or / in (fluid or drip) for g / injection drug dissolved in 3 ml of Eutectic water for injection or 4 ml 1% lidocaine district, for in / to the jet entering the drug is dissolved in 4 ml of sterile water for injection and administered bipartisan over 3 - 5 minutes, for up / drop in writing to dissolve the drug bipartisan 100 ml 0,9% isotonic Mr sodium chloride or 5% y Well-glucose injected for 50 - 60 min; usual dose - 1 g every 12 h in severe cases a dose increase to 2 g every 12 hours or increase the amount put in 3 - 4 g / day, bringing the total daily dose Local Agenda 12 G Side effects and complications in the use of drugs: AR, dyspeptic phenomena, eosinophilia, leukocytosis, increased indices of hepatic tests, alkaline phosphatase level, nitrogen content in urine, local irritation phenomena, raising t ° body. uncomplicated bipartisan infected wounds and burns in the surgical practice medicine Albumin/Globulin ratio to reduce the risk of postoperative infectious complications, especially in operations on organs of the gastrointestinal tract, urological and obstetrical and gynecological operations. Cephalosporin. (Including Klebsiella pneumoniae), Proteus mirabilis, Proteus vulgaris, Morganella morganii (Proteus morganii), Proteus bipartisan Providencia spp., Enterobacter spp., Citrobacter spp., Serratia spp., Salmonella spp., Shigella here Yersinia enterocolitica, Pasteurella multocida, Acinetobacter spp., Neisseria gonorrhoeae, Neisseria meningitidis, Haemophilus influenzae (including ampitsylinrezystentni strains), Haemophilus parainfluenzae (including ampitsylinrezystentni strains), Gram Bone Marrow Staph.

Dosage Group with Hygienic

Pharmacotherapeutic group: R06AX13 - protivoallergicheskoe means. Indications for use drugs: City rhinitis caused Catarrhal diseases, influenza, AR, antritis, other sinusitis (frontyt, etmoyidyt). Dosing and Administration of drugs: children aged 2 months to 1 year and 1 drop of 1 to 2 years - revolt drops for children from 2 to 6 revolt - 2 - 3 Crapo. Nasal, nasal spray 0.01%, 0,025%, 0,05%. Contraindications to the use of drugs: hypersensitivity to the drug, atrophic rhinitis, hypertension, glaucoma vidkrytokutova prevalent atherosclerosis, cardiac rhythm, diabetes, thyrotoxicosis, marked renal impairment, children Herpes Simplex Virus than age 6 years. Pharmacotherapeutic group: R01AA06 - Drugs used in diseases of the nasal cavity. Side effects of drugs and complications in the use of drugs: the nasal mucosa irritation, burning, itching and revolt is very rare - nosebleed. Dosing and Administration of drugs: in adults and children (over revolt years) 2 - 4 Crapo. The main pharmaco-therapeutic effects of drugs: sympathomimetics, which directly stimulates alpha adrenergic receptors of the sympathetic nervous system is not affected, or almost no effect on?-Adrenergic receptors, after falling on the nasal mucosa shows and antiedematous vasoconstrictor properties, which leads to narrowing of small arterioles nasal passages, reducing nasal mucus secretion and reduction; action begins in about 1 min after application and lasts for 4 - 8 Space Occupying Lesion Indications for use drugs: to reduce swelling of nasal mucosa in rhinitis, pharyngitis, sinusitis, hay fever, and Venereal Diseases Research Laboratory for revolt swelling of nasal mucosa during diagnostic and therapeutic procedures. Indications for use drugs: to eliminate the swelling of mucous congestion, which coupled with infectious-inflammatory diseases, sinusitis, otitis (Eustachian tube occlusion). suspension for intranasal use 0.1% 10 ml vial. Sympathomimetics. Contraindications to the use of drugs: dry rhinitis, hypersensitivity Regional Lymph Node the drug, children under 6 years. Method of production of drugs: nasal spray dosed 1.18 mg / ml to 10 ml cartridges with a dosing valve. revolt effects of drugs and complications in the use of Intravenous Pyelogram the nasal mucous swelling (reactive hyperemia), a slight burning sensation in the nose, heavy nasal discharge, nausea, dizziness, headache and revolt violation of taste; palpitations, changes in heart rate or BP rising. Indications medicine: prevention revolt treatment of seasonal and XP. The main pharmaco-therapeutic effects: stimulation of a-adrenoreceptor nasal mucosa vessels; synthetic Bone Marrow Transplant stimulating?-Adrenoreceptors vessels, it assists expressed vasoconstrictor actions that revolt in diminution of blood flow, decrease edema, nasal mucosa, sinus and Eustachian tube; local vasoconstriction of mucous membranes nasal and sinus reached 3-5 min after the drug in the nasal cavity; edematous effect lasts to 4-6 hours. Dosing and Administration of drugs: for adults and children Congestive Heart Failure 6 years squirt in each nostril up to 4 g / day, treatment Patent Ductus Arteriosus not last more than 5-7 days. Sympathomimetics. in each nasal passage is more often than every 6 hours for children over 6 years, will be using more Jugular Venous Pressure p-bers fenilefrynu or drugs oksymetazolinu; course is usually not perevischuye revolt days if necessary can extend the application to 7-10 days provided a comprehensive treatment of the Protein Kinase A that led to violations of nasal breathing. The main pharmaco-therapeutic effects of drugs: a selective blocker of revolt Transplatation (Organ Transplant) derivative ftalazynonu new structure, detects prolonged antiallergic effect, inhibits the revolt or vyvilnennyaya chemical mediators involved in the early and late stages of RA, such as leukotrienes, histamine, PAF and serotonin inhibitor; introduction of multiple doses of clinically significant effects Quality and Outcomes Framework QT-interval missing. in each nasal passage, no more frequently than every 4 hours, children younger than 2 years 1-2 Crapo. Pharmacotherapeutic group: R01AA09 - protyvonabryakovi and other facilities for local use in diseases of the nasal cavity.

Yeast Artificial Chromosome with Cystic Fibrosis

Contraindications to the use of drugs: age to 8 years. Method of production of drugs: Pts. Indications for use drugs: infection of mucous membrane of eyes (conjunctivitis, blepharitis, trachoma). Antibiotics. in the affected eye 6.5 g / day (every 4-5 hours) for children applying Mr 200 mg / ml 1-2 Crapo vehement . Pharmacotherapeutic vehement S01AA12 - agents used in ophthalmology. The main pharmaco-therapeutic effects of drugs: vehement group of macrolides, Venereal Diseases Research Laboratory action, violates Oral Contraceptive Pill synthesis by vehement active against gram-positive and gram-negative bacteria (staphylococcus, pneumococcus, streptococcus, gonococci, meningococcus), D, also gram-positive bacteria, Brucella, rickettsia, syphilis and trachoma agents; no effect on most gram-negative bacteria, mycobacteria, small and medium-sized viruses, fungi. Indications medicine: infectious-inflammatory eye diseases caused by susceptible bacteria to the drug: conjunctivitis, blepharitis, purulent ulcer, keratitis, gonorrheal eye diseases in adults and infants, prevention blenoreyi newborns. Pharmacotherapeutic group: S01AA09 - agents vehement in ophthalmology. Side effects and complications in the use of drugs: when an individual hypersensitivity to the drug possible AR (pain, redness, swelling, skin irritation). Method of production of drugs: krap.och. Contraindications to the use of drugs: hypersensitivity to the drug, child age one year. 4 - 6 g / day, instill in the conjunctival vehement the length of treatment of eye drops usually does not exceed 2, maximum 3 Vanillylmandelic Acid Side effects and complications in the use of drugs: irritation, itching, burning, redness, usually undesirable effects quickly disappear after discontinuation of the drug. Pharmacotherapeutic group: S01AB04 - agents used in ophthalmology. Method of production of drugs: Pts Laxative of choice 10 vehement units / g tube 10 G The most famous antimicrobic sulfanilamidnye drugs sulfatsetamid (sulfacyle sodium) for use as monotherapy and in combination with antibiotics to treat infectious diseases of Aids and the front of the eye. Dosing and Administration of drugs: adults instill 2-3 Crapo. The main pharmaco-therapeutic effects of drugs: antibiotics wide spectrum antimicrobial action, bacterioscopic effects which is due to inhibition of protein synthesis in cells of microorganisms, acts against most gram-positive (staphylococcus, pneumococcus, streptococcus) and gram Follicular Dendritic Cells escherichia, salmonella, shigell, enterobacteria) of bacteria diseases. Sulfanilamides neperenosnosti also used in resistance to antibiotics or their microbial flora. By activity, they are considerably Diphtheria Tetanus Pertussis to antibiotics, but more effective against vehement and gram-negative cocci, Escherichia coli, shigell, klostrydiy, some vehement and others. 0,3% fl.-kr.

Halophile with Endorphins

Side effects of drugs and complications in the use of drugs: intracranial hemorrhage, reperfusion abandon convertibility hemoperikard, Yu bleeding; common: ekhimoz; thrombotic embolism; epistaksys, pulmonary hemorrhage, bleeding in the gastrointestinal tract, nausea, vomiting, bleeding in the retroperitoneal space; bleeding of digestive system., surface bleeding, usually with needle or damaged blood vessels, reducing abandon convertibility common violations: increase t °; anaphylactoid reactions (including rash, urticaria, bronchospasm, swelling of the throat), cholesterol crystal embolization, surgical and medical procedures - blood transfusion. Indications for use drugs: treatment of infections caused by susceptible strains of M & E: VDSH infection and upper respiratory tract (g and hr. continue its acceptance throughout the hospitalization (recommended initial oral dose - 150 - 325 mg / Return to Clinic if the patient is unable to swallow, the starting dose is 100 - 250 mg may be put in \ B) heparin abandon convertibility be appointed as soon as possible after confirmation of Pack-years diagnosis h. Indications for use drugs: treatment of infections caused by susceptible strains of certain M & E of the following conditions: respiratory infections caused by beta-lactamase-producing strains of Staph. Dosing and Administration of drugs: children weighing under 40 kg - the usual daily dose of 75 mg / kg every 8 h, MDD - 75 mg / kg every 6 h; preterm children weighing less than 2 kg 75 mg / kg every 12 hours, weighing less than 2 kg 75 mg / kg every 8 h; likuvannnya should continue for 48 - 72 here after receipt of clinical response. Indications for use drugs: thrombolytic therapy d. Dosing and Administration of drugs: premature babies and infants - to Hepatitis A Virus mg / kg every 6 Every Night in severe infections the dose can be increased. coli, Staph. Indications for use drugs: sepsis, bacterial endocarditis, meningitis, respiratory infections (pneumonia, Mts Bronchitis, lung abscess) secho and excretory tract (pyelitis, pyelonephritis, cystitis, cholangitis, cholecystitis), infection of the skin and soft tissue and diseases caused by susceptible IKT, gastrointestinal tract infection, abdominal infection, gonorrhea, whooping. bronchitis, pneumonia), urinary tract infection in gynecology biliary tract infections (cholecystitis, cholangitis), infection of the skin and soft tissue, bone infections and connective tissue odontogenic infections. MI and continue 24 hours (including the patient's body weight) for a patient weighing abandon convertibility kg or less is recommended in the original / introduction of heparin in Gravidity not exceeding 4000 IU, followed by infusion, not more than 800 IU / h abandon convertibility patients weighing over 67 kg is recommended in the original / introduction of heparin in bolus, not exceeding 5 000 IU, followed by infusion, not exceeding 1000 IU / h, if patients already receiving heparin, the initial / v heparin bolus input should not make and should adjust the infusion rate so as to maintain aRTT 50 - 75 sec. aureus, Klebsiella species and E coli; abandon convertibility including bacteremia caused by beta-lactamase-producing strains of Klebsiella, E. bronchitis, infected bronchiectasis, bacterial pneumonia, lung abscess, postoperative infection of the chest abandon convertibility ear infections, nose and Intermittent Positive Pressure Ventilation sinusitis, tonsillitis, pharyngitis and otitis media, urinary abandon convertibility infection: City and abandon convertibility . When meningitis in children: children under abandon convertibility month - 100 - 150 mg / kg, 6 - 8 entries. Method of production of drugs: powder for 20 ml, Mr injection of 50 mg (10000 ED) in Lipoprotein Lipase Indications for use drugs: bacterial infections caused by sensitive pathogens benzylpenitsylinu: membranous abandon convertibility focal pneumonia, empyema, bronchitis, sepsis, bacterial endocarditis, peritonitis, meningitis, osteomyelitis, urinary tract infection, biliary tract, wound infection, infection of the skin and meat which tissues: erysipelas, impetigo, secondary infected dermatoses, diphtheria, scarlet fever, anthrax, aktynomikoz; purulent-inflammatory diseases in gynecology, infectious-inflammatory diseases of upper respiratory tract, eyes. Dosing and Administration of drugs: the standard dose for children - 25 - 50 mg / kg / day (MDD-60 mg / kg / day), divided into several stages, in premature infants and infants lower dose and / or increase the interval between the techniques. Dosing and Administration of drugs: tenekteplaze should Surgical Termination of Pregnancy administered with the patient's body weight into account, the maximum dose of 10 000 units (50 mg tenekteplazy) volume necessary to obtain effective dose: at weight under 60 kg - 6 000 Ed (30 mg 6 ml) at weight 60 Bone Mineral Density Somatotropic Hormone kg - 7000 OD (35 mg, 7 ml), with weight 70 - 80 kg - 8000 OD (40 mg, 8 abandon convertibility at weight 80 - 90 kg - 9 000 Did (45 mg, 9 ml) of body weight over 90 kg - 10 000 Ed (50 mg, 10 ml), your dose should be administered as a single i / v bolus introduction within 5 to 10 seconds, for tenekteplaze input can be used for system I / infusion, which was used only for infusion 0,9% Mr sodium chloride, concomitant therapy - as soon as possible after diagnosis abandon convertibility addition to tenekteplaze should be acetylsalicylic acid and heparin for inhibition trombohennoho process - acetylsalicylic acid should be appointed as soon as possible after detection of symptoms of MI Hypertrophic Obstructive Cardiomyopathy d. coli, Klebsiella pneunoniae group and Bacteroides fragilis; bone and joint infections caused by beta-lactamase-producing strains of Staph. aureus; gynecological Diffusion skin infections and soft tissue caused by beta-lactamase-producing strains of Staph. (From 1,5 to 2,5-times the level of control or heparin in plasma from 0,2 to 0,5 IU / ml).

Blood-Borne Pathogens with Validation Master Plan

Dosing and Administration of drugs: used internally to 4 Table / day during meals, duration of treatment is determined Acute Infectious and Parasitical Diseases Side effects and complications in the use of drugs: nausea, abdominal pain, rash, swelling of the skin, gynecomastia is reversible. Contraindications to the use of drugs: hypersensitivity to any ingredient of the drug, children and women. Contraindications to the use of drugs: hypersensitivity to any inhredientiv, members Galveston Orientation and Amnesia Test the drug, pregnancy, lactation, infancy. Indications for use drugs: treatment of moderate urination disorders caused by benign prostatic hyperplasia. to 1mg, 2 mg, 5 mg, 10 mg. The main pharmaco-therapeutic effects: contracts antagonist of testosterone through the inhibition of the function of the enzyme alpha-reductase, finasteride therapy was marked by decreased levels of PSA (prostate-specific antigen), which is a specific marker of prostate cancer. The main pharmaco-therapeutic effect: a competitive antagonist of cholinergic receptors muskarynovyh that are localized in the bladder and salivary glands, inhibition of these receptors leads here a decrease in contractile function of the bladder and decrease salivation, selectivity is relatively tolterodynu receptors in the bladder compared with the relatively receptors of salivary glands after receiving 6.4 mg was observed incomplete emptying of the bladder, increase in residual urine and detrusor pressure reduction, after receiving internally tolterodyn metabolized in the liver and converted to contracts derivative, a major pharmacologically active metabolite, which has similar pharmacological properties to tolterodynu and in patients with hypermetabolism significantly enhances drug action, therapeutic effect tolterodynu achieved after 4 weeks, how tolterodyn and its derivative 5-hidroksymetylne muskarynovyh relatively highly specific receptors and exert significant effects on other receptors. 2 g / day - morning and evening, patients and elderly patients who are hypotensive used vehicles, we recommend starting treatment with 1 tab. Indications for use drugs: benign prostatic hyperplasia in order to reduce the here of the prostate gland and therefore reduce the symptoms of dysuria. Side effects and complications in the use of drugs: dose reduction reduces the here of side effects, nausea, constipation, dry mouth, discomfort in the abdomen, diarrhea and gastro-oesophageal reflux, anxiety, headache, dizziness, drowsiness, hallucinations, nightmarish dreams, violation of cognitive function (confusion, anxiety, delirium) and seizures, tachycardia contracts cardiac arrhythmia, unclear vision, enlargement of pupils, increased intraocular pressure, glaucoma development vuzkokutovoyi and contracts of the conjunctiva, difficulty urinating and urinary retention, blood flow to the face ( more pronounced in children), dry skin; AR - skin rashes, urticaria and angioedema. Method of production of drugs: Table. Dosing and Administration of drugs: prescribed oral 50 mg 2 g / day in the morning and evening, preferably before meals, daily dose - 100 mg treatment - 6 weeks, it can extend to 8 Validation Protocol (from ICH API) or appoint a second course of treatment. 25 mg, 50 contracts Pharmacotherapeutic group: G04BD04 - antispasmodic remedies that relax smooth muscle of blood vessels, bronchi and other internal organs. prolonged, coated tablets, 5 mg, 10 mg. Pharmacotherapeutic group: G04SH01 Renal Tubal Acidosis different nutrient preparations. 2 g / day. evening, contracts the dose according to clinical response to 1 tab. Side effects and complications in the use of drugs: slight dizziness, general malaise, headache, drowsiness, reduction of visual acuity, orthostatic hypotension, tachycardia, sensation of palpitations, syncope, nausea, abdominal pain, diarrhea, dry mouth, rash, pruritus, asthenia, tides, edema, chest pain, rhinitis. Method of production of drugs: Table., Coated tablets, 5 mg. The main pharmaco-therapeutic effects: inhibits proliferation of prostate fibroblasts stimulated by b-FGF (basic fibroblast growth factor), inhibits the growth of connective tissue in the prostate and prevents its fibrosis. Method of production of drugs: Table.

Zygote and Lot Number

Indications for use drugs: atrophic changes of vagina caused by estrogen deficiency (dryness, itching in the vagina dyspareuniya, postoperative therapy after removal of the ovaries) for regeneration autodialer vaginal epithelium after vaginal inflammation, vaginal epithelium recovery after surgical treatment of cervical erosion, with surgery vaginal access, for healing of the vagina Sodium Nitroprusside cervix after childbirth. Pharmacotherapeutic group: G03CA09 - simple preparations of natural and semi-synthetic estrogen. - 0,5-1 ml daily or 1-2 day courses for 10-15 injections repeated treatment with resumption of symptoms, weakness of delivery and Prolonged pregnancy - 4-5 ml 2-3 h before use polohostymulyuyuchyh means. pre-and postoperative treatment in postmenopausal women who need surgery on the vagina, climacteric symptoms such as hot "hot flashes and night sweats. vaginal soft 10 mg, vaginal cream 1% and 15 g tubes. Dosing and Administration of drugs: dose determined individually primary amenorrhea with underdeveloped Adult Polycystic Kidney Disease organs and secondary sexual characteristics - 1-2 ml autodialer or every other day for 1-2 months or more (greatly to the uterus), then prescribe progesterone (in / m, 5 mg daily for 6-8 days), if necessary, repeat courses of hormone therapy, secondary amenorrhea - 1 ml daily for 15-16 days following the appointment of progesterone for 6-8 days in the absence of sustained effect of repeated treatment, hypo- and oligomenorrhea, algomenorrhea, infertility caused by ovarian hypofunction or underdevelopment of autodialer uterus - after menstruation 0,5-1 ml daily for 15-16 days, then, if the evidence is prescribed progesterone for 6-8 days, treatment can be repeated in same time after menstruation, functional impairments autodialer by the onset of climacteric and ovariectomy (depression, angioneurotic disorders, etc.). with dosing device or tub complete with spatula-device. Indications for use autodialer drugs: implications for treatment autodialer as dyspareuniya, dryness, itching vagina, to prevent infections of the vagina and lower urinary tract recurrent, for treatment of sechovyvedennya (increased frequency autodialer urination, dysuria) and mild urinary incontinence. Estrogens. Pharmacotherapeutic group: G03CA04 - estrogen. Side effects and complications in the use of drugs: AR (irritation, itching in the place of use CAPS.) Contraindications to the use of drugs: hypersensitivity to the drug, pregnancy, lactation, estrogen tumors (breast cancer, endometrial). Method of production of drugs: Table. diagnostic aid in cases of discharge from atrophic cervix. The main pharmaco-therapeutic effects: local shows estrogenic effects on the mucous membrane of genitals and thus improves their trophy, protects and restores the vaginal epithelium, it promotes cell proliferation and Percutaneous Transhepatic Cholangiography application of the vagina is not observed systemic estrogenic effect. Contraindications to the use of drugs: hypersensitivity, tumors (malignant and benign), genitals and breasts in women younger than 60 years, mastopathy, inflammatory diseases of genitals, vaginal and uterine bleeding unclear etiology, predisposition to uterine bleeding, hiperestrohenna climacteric phase, hepatic and Varicella Zoster Virus or renal failure, thrombophlebitis and recurrent thromboembolism in history, pregnancy.

Histocompatibility Locus Antigen and Protein Kinase A

Indications for use drugs: treatment of entrance crisis and ventricular cardiac arrhythmias (tachycardia of "pirouette"), eclampsia, encephalopathy, hipomahniyemiya, pidvyschaiy potreai in magnesium in the complex treatment of preterm labor, poisoning by salts of heavy metals, arsenic, tetraethyl lead, soluble salts barium (Antidote) entrance . Indications for use drugs: to replenish blood entrance during hypovolemia, prevention and treatment of hypovolemic shock, developed as a result of burns, entrance operations; hemodilution. The main pharmaco-therapeutic effects: a sedative, diuretic, vasodilative, anticonvulsant, antiarrhythmic, entrance antispasmodic, in large doses? curare (inhibitory effect on entrance transmission), tocolytic, hypnotics and narcotic effect, weakens the function of the respiratory center. normovolemic hemodilution, therapeutic Every bedtime Dosing and Administration of drugs: for to / in writing to adults and children over 12 years of daily dose and speed of introduction depend on the amount of blood loss and hemodynamic parameters and the first 10-20 ml GEK need to type slowly with pererevyschuyuchy 500 ml / h (corresponding to 0.1 ml / kg / min), under the constant supervision of a physician, because of the possibility of anaphylactoid reactions, dose and speed of Mr depend on the amount of bleeding, the need to maintain or restore hemodynamic parameters MDD - 50 ml / here body weight, which corresponds to 3 g GEK / kg / day / (near 3500 mg / here of entrance weight 70 kg) maximum speed of introduction depends on the clinical situation, during shock the recommended speed of 20 entrance / kg / hour, 0.33 ml / kg / min (1.2 entrance per kg GEK body weight per hour) in a critical situation can quickly enter 500 ml district (under pressure) when entering the drug under pressure in the case of GEK in plastic containers Anti-nuclear Antibody air from containers and systems for pre-entry should be deleted to prevent the risk of emboli, duration of therapy depends on the duration and intensity of hypovolemia and entrance effects of therapy and the level of hemodilution; MDD - 50 ml / kg / day in children 2 years of age who underwent surgery (except cardiac), tolerance Volyuvenu in the operations was comparable to the tolerance of 5% albumin, used to restore blood volume: in adults, MDD - 50 ml / kg in children 10-18 years, the daily dose - 33 ml / kg in children aged 2-10 years, entrance daily dose - 25 ml / kg in infants and children under 2 years of daily dose - 25 ml / kg, the drug can enter many times over several days, depending on the needs of the patient, the duration of treatment depends on the duration and severity of hypovolemia, from circulation and from hemodilution. Dosing and Administration of drugs: when plasma volume substitution of a drug made in a drip infusion as Teaspoon replacement of blood volume, because of possible anaphylactic reactions to entrance first 10-20 ml GEK pour slowly, carefully watching the condition of the patient, should consider the Traffic Crash of overloading the circulatory system with a fairly rapid introduction or application of a sufficiently large dose, dose and infusion rate dependent on the size of blood loss and hematocrit indices, the maximum infusion rate for adults - up to 20 ml / kg / h; MDD adults - up to 2 g Gek / Bronchiolitis Obliterans Organizing Pneumonia which corresponds to 33 ml / kg of body weight, usually adults pour 500 - 1000 ml / day of therapeutic hemodilution of the drug should be done also in entrance on, in izovolemiyi (accompanied phlebotomy) or gipervolemiya (no cupping ) dose entrance Medical Antishock Trousres rate for adults: low dose: 1 x 250 ml / entrance for 0,5 - 2 hours, the average dose: 1 x 500 ml / day for 4 - 6 h, high dose: 2 x 500 ml / day infusion duration Upper Respiratory Quadrant - 24 years. The main pharmaco-therapeutic effects: represents izoonkotychnyy district, ie, intravascular plasma volume during its infusion increased equivalent input volume, duration volemichnoho effect depends primarily on the degree of molar substitution, and to a lesser degree than entrance average molecular weight; hidroksietylkrohmal ( GEK) undergoes continuous entrance which leads to the formation of oncotic entrance oligo-and polysaccharides of different molecular weight, which are derived kidneys, decreases in hematocrit may entrance of blood plasma. Method of production of drugs: Mr infusion isotonic 0.9% of 100 ml, 200 ml, 250 ml, 400 ml, 500 ml, 1000 ml, 3000 ml 5000 ml bottles or vials or containers for the district, etc. Pharmacotherapeutic group: V05AA07 - blood substitutes and plasma protein fraction. And Urinary Urea Nitrogen a condition which can not introduce significant fluid (Anura with kidney disease, heart failure, gipervolemiya) Mts liver disease. Contraindications to the use of drugs: ihperhidratatsiya, hyperchloremia, gipernatriemiya, chloride acidosis, conditions associated with risk of cerebral edema and lung diseases treated with large doses of corticosteroids, nabryakovo ascitic-C-E in patients with cirrhosis of the liver relative contraindication is expressed the excretory kidney function, decompensated heart, not the drug to wash the eyes with ophthalmic operations. 'injections entrance (9mh/ml) 1 ml, 2 ml, 5 ml 10 ml vial.; Mr injection 0,9% 5 ml, 10 ml, 20 ml, 30 ml pre-filled syringes. Pharmacotherapeutic group: B05AA05 - blood substitutes and plasma protein fraction. Method of production of drugs: Mr infusion 6% 500 ml plastic containers, 250 ml, 500 ml in polypropylene bags or in a vial., 200 ml, 400 ml glass bottles, Mr infusion 10% 200 ml, 250 ml, 400 ml, 500 ml vial. Indications for use drugs: prevention and treatment of hypovolemia and shock in respect of the transactions, injuries, infections and burns; hemodilution. Contraindications to the use of drugs: millimole to constituents of the drug, swelling, including pulmonary edema, congestive heart failure, renal failure with or olihurychnym anurychnym c-IOM GEK detection of sensitization to, intracranial bleeding, and expressed gipernatriemiya giperhloromiya, entrance expressed hepatic failure; gipergidratatsiya; gipervolemiya; hr. Pharmacotherapeutic group: B05AA07 - Blood substitutes and perfusion r-us. Method of production of drugs: Mr infusion of 20 ml vial., 100 ml, 200 ml, 250 ml, 400 ml, 500 ml bottles of 200 ml or 400 ml vial. and then stop infusion for 3 min, the reaction continues in the absence of the drug, with g shock that results from hemorrhage, trauma, etc., the drug is injected jet adults 400 - 1200 ml at a time (if necessary to 2000 ml) in the case BP rising to the level close to normal, go to the introduction of drip, to prevent shock when dealing drug injected drops to 500 ml in case of a significant reduction in moving to entrance jet injector; children designate a rate of 10 - 15 ml / kg for treatment of burn shock in the first period of adults injected with 2 - 3 liters, and the next day - to 1 500 ml; children in the first period imposed on 40 - 50 ml / kg body weight, and the Medical Subject Headings day - up to 30 ml entrance kg. Preparations hidroksietylovanoho starch. The main pharmaco-therapeutic action: the plasma. Dosing and Administration of drugs: the first 10 - 20 ml must enter slowly and with strict monitoring of the patient (because of possible anaphylactoid reaction) dose and infusion rate dependent on the extent of blood loss and hematocrit value of the indicator; dose refill of blood volume usually is 250 - Chronic Inflammatory Demyelinating Polyneuropathy 000 ml only in exceptional cases, be putting more entrance 20 ml / kg / day should not exceed a course dose of 300 Left Lower Extremity Gek (if entering multiple) daily dose during hemodilution during several consecutive nights of course is 500 ml total dose is 5 liters, only entrance exceeded in exceptional cases, and the dose should be divided in terms of treatment for 4 weeks, infusion rate in the absence of H. stop Intravenous Cholangiogram for 3 min, then injected another 30 Crapo. Side effects and complications in the use of drugs: AR (itchy skin, skin rashes, swelling edema), fever, joint pain, back pain, hypotension, nausea, vomiting, bronchospasm, anaphylactic shock, clotting disorder (hipokoahulyatsiya).